Project Grant R37CA309117
Award Date 6/15/26
Completion Date 5/31/31
Dollars Obligated $650K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Orange, CA 92866, USA
Similar Awards
- Grant Award Summary Duke University received a $906,306 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) awarded September 11, 2025, with completion targeted for August 31, 2028. The award funds development and testing of a telehealth-delivered, cue-based treatment intervention designed to promote smoking cessation among people who smoke lightly (PSLI), defined as those smoking 10 cigarettes per day or fewer. Building...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pennsylvania a Project Grant of $663,554 under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 18, 2025, with an ultimate completion date of July 31, 2030. This research project, titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit," will develop and test harm reduction product sampling as a pragmatic...
- Federal Grant Award Summary The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded the University of Alabama a Project Grant of $2,524,071 on September 23, 2025, for research investigating the neurocomputational mechanisms underlying self-regulation and reinforcement learning in smoking cessation decisions. The four-year project, with completion scheduled for August 31, 2029, will employ computational model-based multimodal neuroimaging...
- Federal Project Grant Award Summary Chapman University received a $534,925 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) for the period April 1, 2026 through March 31, 2029. The project, "Peptide-Drug Conjugates Targeting EGFR for Improved Efficacy of Chemotherapy," focuses on developing novel peptide-drug conjugates (PDCs) that selectively target triple-negative breast cancer (TNBC) cells through epidermal growth...
- Federal Grant Award Summary Award Details: Temple University received a $522,235 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), effective June 1, 2026 through May 31, 2031. The award supports research examining social networks and tobacco cessation in high-risk populations, specifically emerging adults aged 18-26. Products and Services: The project delivers empirical research using mixed methods to identify...
- Federal Project Grant Award Summary Chapman University received a $415,500 Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), awarded June 19, 2025, with completion targeted for May 31, 2028. The award supports research to develop peptide-doxorubicin (DOX) conjugates as improved chemotherapy delivery systems. Doxorubicin is an FDA-approved anthracycline drug used to treat multiple cancer types, but its clinical application is limited...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $694,182 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), effective June 1, 2026 through May 31, 2031. This award funds a prospective longitudinal cohort study examining biomarker levels and respiratory health effects associated with exposure to electronic cigarettes (ECs) and combustible cigarettes (CCs) in young children. The...
- Federal Project Grant Award Summary The University of Pennsylvania received a $460,857 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective August 1, 2025, through July 31, 2030. The award funds the development and delivery of a comprehensive Tobacco Treatment Implementation (TTI) training program designed to build clinical capacity for tobacco cessation interventions across healthcare organizations serving high-burden...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pittsburgh a $2.2 million Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 7, 2025, with a completion date of July 31, 2029. This basic experimental study with humans addresses smoking cessation and craving by investigating dyadic processes between romantic partners and smoking friends. The research integrates theoretical and methodological approaches from...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Virginia Polytechnic Institute & State University a $395,248 Project Grant effective August 11, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct proof-of-concept and feasibility testing of episodic future thinking (EFT) interventions for smoking cessation. This two-year project, concluding July 31, 2027, will develop and evaluate both generalized EFT and cancer-specific EFT approaches...